Blogs, Commentary & News

PTAB’s denial of motion to amend was arbitrary and capricious

09/08/2016

The Federal Circuit continues to show interest in the amendment process for PTAB proceedings. In addition to accepting In re Aqua Products for en banc review of the current standards for amending claims in PTAB proceedings, last week the Federal Circuit issued a decision in Veritas Tech. v. Veeam Software Corp., No. 2015-1894 (Fed. Cir. Aug. 30, […]

On remand, PTAB says it did consider an exhibit submitted to show the “state of the art”

09/02/2016

In a decision on remand issued on August 15, 2016, a PTAB panel again found patentable claims 1-30 of Verinata Health’s U.S. Patent No. 8,318,430, directed to methods for determining the presence or absence of fetal aneuploidy in a fetus. This time, the PTAB specifically addressed the applicability of an exhibit to the state of the art, responding […]

En banc Federal Circuit to review standards for amending claims in PTAB proceedings

08/17/2016

On August 12, 2016, the Federal Circuit granted the petition for rehearing filed in In re Aqua Products Inc. and decided that its full panel of judges will consider the PTAB’s current practice for allowing (or, in most cases, not allowing) claim amendments. Amendments in PTAB proceedings are currently guided by the Informative Opinion issued in Idle Free Systems, Inc. v. Bergstrom, […]

Obviousness at the PTAB: Use common sense with care.

08/12/2016

On August 10, 2016, in Arendi v. Apple et al., the Federal Circuit reversed a final written decision in which the PTAB held that claims were unpatentable as obvious, finding that the PTAB had improperly relied on common sense to fill a gap in the primary prior art reference. The court acknowledged that, post-KSR, common […]

Obviousness prior art: From many comes one?

07/29/2016

On July 27, 2016, the PTAB issued five written decisions finding all claims of six patents assigned to Jazz Pharmaceuticals Inc. unpatentable. Each of the patents related to tracking and controlling the distribution of sensitive prescription drugs that have the potential to be abused, misused, or diverted. An interesting aspect of these decisions is the collective […]

Put it all in the Petition, and with particularity. PTAB authority is limited to unpatentability theories spelled out with specificity in the petition.

07/27/2016

On July 25, 2016, the Federal Circuit reversed a PTAB finding of unpatentability because the decision was based on unpatentability theories never presented by the petitioner and that were not supported by the record. In re: Magnum Oil Tools Int’l, No. 2015-1300 (Fed. Cir. July 25, 2016). The proceeding began when McClinton Energy Group filed […]

Post Grant Review on the rise?

07/26/2016

Post Grant Review (PGR) has technically been available as an option since September 16, 2012. But since only AIA patents are eligible for PGR, it wasn’t until 2015 that PGR-eligible patents began appearing in significant numbers. Today, many of the patents that issue are eligible for PGR. Although the number of PGR petitions filed each year […]

Oregon beer growler patent duel to proceed on multiple fronts

07/22/2016

Drink Tanks Corporation sued GrowlerWerks, Inc. last November for patent infringement based on its sale of growlers, including the uKeg 64 product shown below. Earlier this year, the case was transferred from Delaware to Oregon district court. On June 2, 2016, GrowlerWerks took the fight to the U.S. Patent and Trademark Office (PTO) by filing a […]

Debut of new PTAB filing and case management system – PTAB E2E

07/12/2016

The “PRPS” e-filing and case management system for post-grant proceedings was retired this past weekend.  The new system, PTAB End to End (PTAB E2E), provides significant improvements over the former PRPS system. The new and improved features of PTAB E2E include: Additional search filters, including the ability to search proceedings by party name, type of […]

Supreme Court issues Cuozzo decision: BRI stands; institution decisions not reviewable

06/20/2016

Earlier today, the Supreme Court issued its decision in Cuozzo.  The decision preserves the status quo for PTAB trials by (1) confirming that decisions to institute trial by the PTAB are not reviewable and (2) finding that the PTAB reasonably acted within its rulemaking authority in construing claims under the broadest reasonable interpretation (BRI) standard. Institution Decision Not Reviewable:  […]